Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-11-15
著者
-
UIKE Naokuni
Department of Hematology, National Kyushu Cancer Center
-
ANDO Kiyoshi
Department of Hematology/Oncology, Tokai University School of Medicine
-
谷脇 雅文
高知工科大学工学部
-
Maruyama Dai
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
TOBINAI Kensei
Hematology and Stem Cell Transplantation Divisions, National Cancer Center Hospital
-
OGURA Michinori
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Tobinai K
Hematology And Stem Cell Transplantation Divisions National Cancer Center Hospital
-
Tobinai Kensei
国立がんセンター中央病院 血液内科グループ
-
TAWARA Masayuki
Nagasaki CML Study Group
-
TANIWAKI Masafumi
Department of Environmental Systems Engineering, Kochi University of Technology
-
Kato T
Department Of Gastroenterological Surgery Aichi Cancer Center Hospital
-
ISHIZAWA Kenichi
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
Usubuchi Noriko
国立がんセンター中央病院
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Graduated School Of Medicine
-
Tateishi Ukihide
国立がんセンター中央病院 画像診断グループ
-
Tateishi Ukihide
Yokohama City Univ. Kanagawa Jpn
-
Tateishi Ukihide
Department Of Radiology Yokohama City University School Of Medicine
-
Tateishi Ukihide
Department Of Diagnostic Radiology Graduate School Of Medicine Yokohama City University
-
Tateishi Ukihide
Department Of Radiology Yokohama City University Hospital Graduate School Of Medicine
-
Tateishi Ukihide
国立がんセンター中央病院 放射線診断部
-
Takayama K
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsukasaki Kunihiro
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tanimoto Kazuki
国立がんセンター中央病院
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Kyushu Cancer Center Hospital
-
Uike N
National Kyusyu Cancer Center
-
Uike Naokuni
The Department Of Hematology National Kyushu Cancer Center Hospital
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
神戸大学 医学研究科腫瘍内科学
-
Itoh K
Department Of Chemistry Faculty Of Science Kobe University
-
ANDO Kiyoshi
Tokai University
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Taniwaki Masafumi
Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Kanamaru Akihisa
Kinki Univ. School Of Medicine Osaka‐sayama Jpn
-
Kanamaru A
Department Of Hematology Kinki University School Of Medicine
-
Usui N
Division Of Hematology And Oncology Department Of Medicine Jikei University
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa K
Department Of Rheumatology And Hematology
-
Ishizawa Kenichi
Department Of Rheumatology And Hematology Tohoku University School Of Medicine
-
Ishizawa Kenichi
国立がんセンター東病院
-
UCHIDA Toshiki
Department of Hematology, Nagoya Daini Red Cross Hospital
-
TAKEYAMA Kunihiko
National Cancer Center Hospital
-
OGITA Masami
Sapporo National Hospital
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Iwanaga Masako
Nagasaki Univ. Graduate School Of Biomedical Sci. Nagasaki Jpn
-
Iwanaga Masako
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Tsubaki K
Kinki Univ. School Of Medicine Osaka Jpn
-
Tsubaki Kazuo
浜松医科大学 第3内科
-
Tsubaki Kazuo
近畿大学 産婦人科
-
Usui N
Jikei University Hospital
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Kuroishi Tetsuo
愛知県がんセンター研究所
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Ishizawa Kenichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
CHOI Ilseung
Department of Medicine and Bioregulatory Science, Graduate School of Medical Science, Kyushu Univers
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Hematology And Oncology Division National Cancer Center Hospital East
-
Itoh Kuniaki
Department Of Chemistry Faculty Of Science Kobe University
-
Kawase Ichiro
大阪大学 医学系研究科機能診断科学
-
Uike Naokuni
Department Of Hemato-oncology Kyushu Cancer Center
-
Tobinai K
National Cancer Center Hospital Tokyo Jpn
-
Tobinai Kensei
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Choi Ilseung
Department Of Hematology Kyushu Cancer Center
-
Choi Ilseung
Department Of Hematology National Kyushu Cancer Center
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Tsukasaki K
Department Of Internal Medicine Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Tsukasaki Kunihiro
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Usui Noriko
Jikei Univ. Hospital Tokyo Jpn
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Ikegame K
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ikegame Kazuhiro
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ogura M
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Kinoshita Tomohiro
Mie University
-
Tobinai Kensei
National Cancer Center Hospital
-
Tobinai Kensei
Department Of Pharmacotherapy National Cancer Institute
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine And Dentistry
-
Ogura Michinori
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center Hospital
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Ichimura Kouichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Koshikawa Takashi
Aichi Prefectural College Of Nursing & Health
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Taniwaki Masafumi
The Third Department Of Internal Medicine Kyoto Prefectural Medical School
-
Kikuchi Ako
Tokai University
-
Itoh Kuniaki
Contributors Special Connittee On 'mechanism And Chemotherapy For Adult Refractory Leukemia&apo
-
Uchida Toshiki
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Kinoshita Tomohiro
Department Of Hematology Nagoya University School Of Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Tanimoto K
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Itoh Kuniaki
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
SHIMADA Naomi
Oncology Translational Medicine Department, Novartis Pharma K. K. Japan
-
KOBAYASHI Ken
Oncology Translational Medicine Department, Novartis Pharma K. K. Japan
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University School Of Medicine
-
Ogura Michinori
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Tabata Masahiro
The Department Of Internal Medicine Ii Okayama University Medical School
-
Tsukasaki Kunihiro
The Department Of Haematology Of Atomic Disease Institute Nagasaki University School Of Medicine
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Maruyama Dai
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Shimada Naomi
Oncology Translational Medicine Department Novartis Pharma K. K. Japan
-
Choi Ilseung
Department Of Hematology And Oncology National Kyushu Cancer Center
-
Uike Naokuni
Department Of Hematology National Organization Kyushu Cancer Center; Fukuoka Japan
-
Ichimura Koichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Uchida Toshiki
Department Of Hematology And Oncology Nagoya Daini Red Cross Hospital
-
Ishizawa Kenichi
Department Of Breast Oncology And Hematology/medical Oncology National Cancer Center Hospital East
-
Kobayashi Ken
Oncology Translational Medicine Department Novartis Pharma K. K. Japan
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
TATEISHI Ukihide
Department of Radiology, Yokohama City University Graduate School of Medicine
関連論文
- Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan : a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group
- 特集「顕微鏡法による材料開発のための微細構造研究最前線(8)-照射効果の解明と耐照射材料および新素材開発をめざして-」の企画にあたって
- Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy : case report and review of the literature
- Stromal cells in bone marrow play important roles in pro-inflammatory cytokine secretion causing fever following bortezomib administration in patients with multiple myeloma
- Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
- Nocardia exalbida brain abscess in a patient with follicular lymphoma
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
- イオン注入法によるFe及びCu超微粒子形成とGMR特性(第17回「電磁力関連のダイナミクス」シンポジウム)
- 24pYF-11 GaSb, InSbの電子線照射効果(格子欠陥・ナノ構造(半導体),領域10,誘電体,格子欠陥,X線・粒子線,フォノン物性)
- 点欠陥の自己組織化的挙動を利用した微細構造形成法
- イオン照射で導入される点欠陥を利用したナノセル構造の形成
- イオン照射によって導入された点欠陥によるセル構造の形成
- イオン照射による半導体微細セル構造の自己組織化形成
- 低温でのSnイオン注入によってGaSb表面に形成される特異な欠陥構造とその形成機構
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
- Non-hematopoietic Mesenchymal Stem Cells can be Mobilized and Differentiate into Cardiomyocytes after Myocardial Infarction(Development and Differentiation 3 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Transplanted Bone Marrow Stem Cells Move to the Infarcted Myocardium and Regenerate the Heart
- Epstein-Barr virus involvement is a predictive factor for the resistance to chemoradiotherapy of gastric diffuse large B-cell lymphoma
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- t(11 ; 18)-Bearing Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Responding to Cladribine
- Two Entities of Precursor T-Cell Lymphoblastic Leukemia/Lymphoma Based on Radiologic and Immunophenotypic Findings
- Primary Mediastinal Large B-Cell Lymphoma : A Single-Institution Clinical Study in Japan
- EBV-Positive Burkitt Lymphoma as a Late-Onset Posttransplantion Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation
- Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
- Successful Allogeneic Bone Marrow Transplantation in a Case of Adult Precursor B-Lymphoblastic Lymphoma
- AuCu合金の相転移と熱膨張挙動
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Therapy-Related Leukemia and Myelodysplastic Syndrome: A Large-scale Japanese Study of Clinical and Cytogenetic Features as Well as Prognostic Factors
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Polymorphism of dihydropyrimidine dehydrogenase (DPYD) Cys29Arg and risk of six malignancies in Japanese
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Expression of Human Tumor-Associated Antigen RCAS1 in Adult T-Cell Leukemia/Lymphoma
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Prognostic Significance of FLT3 Internal Tandem Duplication and NPM1 Mutations in Acute Myeloid Leukemia in an Unselected Patient Population
- Prospective isolation of regenerated cardiomyocytes from the mixture of mesenchymal stem cells
- Adult T-Cell Leukemia-Lymphoma Successfully Treated with 2-Chlorodeoxyadenosine
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Oncogene Associated cDNA Microarray Analysis Shows PRAME Gene Expression is a Marker for Response to Anthracycline Containing Chemotherapy in Patients with Diffuse Large B-cell Lymphoma
- 白滝鉱山が地域にもたらしたもの
- 「わが国の鉱業の過去, 現在そして未来」の企画にあたって
- 小特集の企画にあたって
- CORRELATION BETWEEN SEVERITY OF PARKINSONISM AND DOPAMINE NEURONAL DAMAGE IN MPTP-TREATED MARMOSETS
- Ex vivo evidence for asymmetric tyrosine phosphorylation of ZAP-70 on double-positive thymocytes in the positive selection process
- Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia : a single-center analysis of 47 patients
- Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma
- 3 Lesson from GFP^+ bone marrow transplanted mice : Regeneration of infarcted myocardium by cytokine administration(Symposium 8 (SY8) (M) : Regeneration Medicine of Cardiovascular Diseases)(Special Program)
- 3-Dimensional Coronary Angiography in Mice Using Confocal : Laser Scanning Microscopy
- Monitoring Minimal Residual Disease in Patients With MLL-AF6 Fusion Transcript-Positive Acute Myeloid leukemia Fllowing Allogeneic Bone Marrow Transplantation
- Void Formation and Structure Change Induced by Heavy Ion Irradiation in GaSb and InSb
- Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
- Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era
- Concurrent Murine Cytomegalovirus and Klebsiella pneumoniae Infections in Germfree Mice
- Immunological Responses in Germfree Mice Infected with Murine Cytomegalovirus
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Treatment of Indolent Non-Hodgkin's Lymphoma with Cladribine as Single-Agent Therapy and in Combination with Mitoxantrone
- Human CD34^- Hematopoietic Stem Cells: Basic Features and Clinical Relevance
- Proteasome inhibitor, bortezomib, for myeloma and lymphoma
- Characteristics of CD5-Positive Splenic Marginal Zone Lymphoma with Leukemic Manifestation ; Clinical, Flow Cytometry, and Histopathological Findings of 11 Cases
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Bortezomib for post-allogeneic hematopoietic stem transplantation relapse and GVHD in multiple myeloma : a single institute experience
- Bortezomib plus dexamethasone for relapsed or treatment refractory multiple myeloma : the collaborative study at six institutes in Kyoto and Osaka
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I and pharmacokinetic study of bendamustine hydrochloride in relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
- Formation of Defect Structure on Ge Surface by Ion Irradiation at Controlled Substrate Temperature
- Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
- Phase I study of LY2469298, an Fc-engineered humanized anti-CD20 antibody, in patients with relapsed or refractory follicular lymphoma
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
- Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes
- Intravascular B-cell lymphoma with hypercalcemia as the initial presentation
- Heterogeneity in clonal nature in the smoldering subtype of adult T-cell leukemia : continuity from carrier status to smoldering ATL
- Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
- Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes